GTS Securities’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$589K Sell
1,198
-2,633
-69% -$1.43M 0.02% 654
2025
Q4
$2.22M Buy
3,831
+1,885
+97% +$1.07M 0.08% 202
2025
Q3
$944K Buy
1,946
+907
+87% +$422K 0.04% 447
2025
Q2
$421K Sell
1,039
-1,889
-65% -$790K 0.02% 736
2025
Q1
$1.46M Sell
2,928
-158
-5% -$85.6K 0.06% 252
2024
Q4
$1.61M Sell
3,086
-2,056
-40% -$1.13M 0.08% 191
2024
Q3
$3.18M Buy
5,142
+2,953
+135% +$1.75M 0.01% 1230
2024
Q2
$1.21M Buy
2,189
+1,710
+357% +$980K ﹤0.01% 1896
2024
Q1
$278K Sell
479
-6,608
-93% -$3.71M ﹤0.01% 3059
2023
Q4
$3.76M Buy
7,087
+4,344
+158% +$2.1M 0.01% 1201
2023
Q3
$1.39M Buy
+2,743
New +$1.46M ﹤0.01% 1773

Other funds holding TMO

GTS Securities's TMO Position: Q1 2026 in Review

GTS Securities reduced its Thermo Fisher Scientific (TMO) stake by 69% in Q1 2026, selling an estimated $1.43M and leaving 1,198 shares worth $589K. The position accounts for 0.02% of the portfolio, ranked #654.

GTS Securities first reported a position in TMO in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.76M in Q4 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • GTS Securities held 1,198 shares of Thermo Fisher Scientific worth $589K as of Q1 2026.
  • GTS Securities sold 2,633 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.43M.
  • Thermo Fisher Scientific made up 0.02% of GTS Securities's portfolio in Q1 2026, its #654 holding.
  • GTS Securities first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's Thermo Fisher Scientific position peaked at $3.76M in Q4 2023.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.